2021 Gordon Moore Award for Excellence in Mentoring Recipient Named
The Institute upholds a strong tradition of mentorship to support professional and personal development of faculty and staff at all stages of career development. To celebrate the outstanding Institute members who inspire, support, and catalyze the personal and professional development of colleagues, the Gordon Moore Award for Excellence in Mentoring was established in 2019.
Named for and inspired by Gordon Moore, MD, MPH, the award was created to recognize exceptional mentors from all areas, including staff, research scientists, analysts, fellows, faculty, and individuals in administrative and management roles. Mentors can be recognized for one or more of the following traits:
Goal setting | Developing talent | Coaching and sponsorship | Role modeling | Support |
Feedback and caring | Commitment | Encouraging high expectations | Fostering values of life-long mentoring | Supporting work-life balance
A nomination for excellence in mentoring appreciates an individual who has had a transformative role in the professional or personal development of one or more mentees. The committee is excited to honor this year's mentor. Congratulations goes to:
Ann Chen Wu, MD, MPH
Ann Chen Wu MD, MPH is the Ruth Sager Endowed Associate Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute. She is the Director of the Center for Healthcare Research in Pediatrics (CHeRP) and the PRecisiOn Medicine Translational Research (PROMoTeR) Center. Additionally, she is a practicing pediatrician at Boston Children's Hospital. After receiving her BS in Biology from the Massachusetts Institute of Technology (MIT) and her MD from Harvard Medical School, Dr. Wu completed her pediatrics residency at Boston Children's Hospital and completed fellowship training in the Harvard Pediatric Health Services Fellowship. She received an MPH from the Harvard T.H. Chan School of Public Health.
Dr. Wu's research focuses at the intersection of genetic epidemiology and health services research. Dr. Wu is currently leading the Age-Dependent Pharmacogenomics of Asthma Treatment (ADAPT) study, which has the goal of elucidating how age modulates genetic, genomic, and metabolomic information on response to asthma medications. In addition, Dr. Wu leads the development of the Precision Medicine Prevention and Treatment Model (PreEMPT), which applies modeling methods to genomic technologies.